Mucin Production Analysis
Mucin Production Analysis - Related Videos
11:39
Using Unfixed, Frozen Tissues to Study Natural Mucin Distribution
0 Views •
Cited by 39 •
2012
Unfixed frozen tissue samples embedded in Optimal Cutting Temperature medium (OCT) can be used to study natural distribution and glycosylation of secreted mucus. In this approach tissue processing is minimal and the natural presentation of glycolipids, mucins and glycan-epitopes is preserved. Tissue sections can be analyzed by immunohistochemistry using fluorescence or chromogenic detection.
09:24
Mucin Agarose Gel Electrophoresis: Western Blotting for High-molecular-weight Glycoproteins
0 Views •
Cited by 32 •
2016
Mucins are high-molecular-weight glycoconjugates, with size ranging from 0.2 to 200 megadalton (MDa). As a result of their size, mucins do not penetrate conventional polyacrylamide gels and require larger pores for separation. We provide a detailed protocol for mucin agarose gel electrophoresis to assess relative quantification and study polymer assembly.
08:51
Profiling of Permethylated Mucin O-glycans Using Matrix-assisted Laser Desorption/Ionization Time-of-flight Mass Spectrometry
0 Views •
2025
Here, we present a detailed protocol for the release of O-glycans from mucins, and the subsequent desalting, permethylation, and analysis using MALDI-TOF mass spectrometry.
10:10
Robotic Duodenum-preserving Total Pancreatic Head Resection for Intraductal Papillary Mucinous Neoplasms
0 Views •
2026
This protocol presents robotic duodenum-preserving total pancreatic head resection (R-DPPHRt) for intraductal papillary mucinous neoplasms (IPMNs). A video demonstrates the technique in a patient with main duct-IPMN, highlighting its feasibility as a minimally invasive, organ-preserving alternative to pancreaticoduodenectomy.
06:47
Measurement and Analysis of Extracellular Acid Production to Determine Glycolytic Rate
0 Views •
Cited by 103 •
2015
Glycolysis is a defining metabolic marker in multiple biological systems. Monitoring glycolysis by measuring the extracellular flux of H+ is common, but requires correction to be quantitative and unambiguous. Here, we demonstrate how to gather and correct extracellular flux data to distinguish between respiratory and glycolytic sources of extracellular acidification.
FAQs
Mucin production analysis can distinguish changes in production from changes in release by pairing readouts of mucin gene expression with measurements of mucin protein or secreted material. Gene-level results indicate altered synthesis programs, whereas protein and carbohydrate-rich measurements show accumulated or released mucin. Using more than one readout helps clarify how epithelial responses change after inflammatory or pathogen exposure.
The carbohydrate-rich portion matters because mucins are heavily glycosylated proteins. Therefore, assays that detect carbohydrate-rich material can provide evidence of mucin abundance or secretion without measuring a specific gene. This readout is particularly relevant when the research question concerns the mucus barrier itself, including whether epithelial protection changes after environmental or microbial challenge.
Immune signaling can influence epithelial mucin responses by changing the amount of mucin produced or released. Comparing untreated cells with cells exposed to inflammatory signals allows investigators to associate immune activation with altered barrier output. In infection studies, the same design can show whether a pathogen-associated condition changes epithelial protection, clarifying how host responses and microbial effects interact at mucosal surfaces.
Gene expression, protein levels, and carbohydrate-rich material address different aspects of the response. Gene measurements indicate changes in mucin-related synthesis activity, protein measurements assess mucin abundance, and carbohydrate-based measurements reflect the glycosylated material that contributes to the mucus barrier. Selecting one or combining several readouts should match whether the study focuses on synthesis, abundance, or secretion.
Mucin production analysis may use epithelial cell cultures, tissue samples, or biological fluids. Cell cultures provide a controlled setting for examining epithelial responses, tissue samples show changes within an organized biological site, and fluids can be assessed for released material. Across these settings, investigators can measure gene expression, protein levels, or carbohydrate-rich material after relevant inflammatory or infectious exposure.
A basic workflow begins by selecting epithelial cells or another sample type, applying an inflammatory signal or pathogen when relevant, and collecting the resulting cells, tissue, or fluid. Investigators then measure gene expression, mucin protein, or carbohydrate-rich material and compare the results with an appropriate unexposed condition. This sequence links the experimental challenge to changes in mucin production or secretion.
In immunology and infection research, these measurements help determine whether host cells strengthen or weaken mucosal barrier defenses during disease-related conditions. Studies can address respiratory, gastrointestinal, or reproductive infections, where altered mucus production may reflect epithelial responses to microbes or immune signaling. The findings can also support evaluation of therapeutic strategies intended to restore mucosal function.